SCHEMBL4522383

SCHEMBL4522383

COc1ccc(-c2[nH]c3ccc(Oc4c(Cl)cc(CC(=O)O)cc4Cl)cc3c2C)cc1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
THRB P10828 17/20 0.52
THRA P10827 16/20 0.52
PPARG P37231 1/20 0.50
ALOX5 P09917 1/20 0.47
AKR1C2 P52895 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4508675 0.92 THRB (0.61) THRBTHRA
SCHEMBL3990040 0.91 THRB (0.52) THRBTHRA
SCHEMBL4532920 0.90 THRA (0.49) THRBTHRAPPARGALOX5AKR1C2
SCHEMBL3990206 0.90 THRA (0.48) THRBTHRAPPARG
SCHEMBL3995101 0.84 THRB (0.56) THRBTHRAAKR1C2
SCHEMBL4527795 0.82 THRB (0.52) THRBTHRAPPARGALOX5
SCHEMBL3990201 0.82 THRA (0.39) THRBTHRAPPARGALOX5
SCHEMBL4518429 0.80 ALOX5 (0.47) THRBTHRAPPARGALOX5AKR1C2
SCHEMBL4528982 0.78 THRA (0.49) THRBTHRAPPARGALOX5AKR1C2
SCHEMBL3990450 0.78 THRB (0.54) THRBTHRAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO claimed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
WO-2009080835-A1 THYROMIMETRIC COMPOUNDS IN TREATMENT OF DISEASE RELATED TO SONIC HEDGEHOG SIGNALLING KARO BIO AB (SE) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA THRB 4/4885THRA 3/4885PPARG 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.